Zylox-Tonbridge Medical Technology (HKG: 2190), a China-based developer of nerve and peripheral vascular interventional devices, has secured marketing approval from the National Medical Products Administration (NMPA) for its flow diverter (FD). This device represents a significant advancement in the treatment of intracranial aneurysms, particularly large and giant aneurysms.
Notably, this product is the first domestically manufactured fully developed remote closed dense mesh stent. It incorporates a nickel-titanium alloy wrapped in platinum for enhanced imaging capabilities, coupled with a closed design that facilitates remote imaging. The FD outperforms comparable products on the market with superior adhesion and imaging performance during surgical procedures, thereby enhancing both visibility and safety in intraoperative settings. Furthermore, the comprehensive range of models available allows for tailored treatment options to address various clinical needs.- Flcube.com
